5ELI
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 5eli by Molmil](/molmil-images/mine/5eli) | Triggering receptor expressed on myeloid cells 2 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Triggering receptor expressed on myeloid cells 2 | Authors: | Brett, T.J, Kober, D.L. | Deposit date: | 2015-11-04 | Release date: | 2016-12-28 | Last modified: | 2023-09-27 | Method: | X-RAY DIFFRACTION (3.0977 Å) | Cite: | Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms. Elife, 5, 2016
|
|
6BA9
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 6ba9 by Molmil](/molmil-images/mine/6ba9) | YbtT - Type II thioesterase from Yersiniabactin NRPS/PKS biosynthetic pathway- S89A mutant | Descriptor: | Iron aquisition yersiniabactin synthesis enzyme, YbtT | Authors: | Brett, T.J, Kober, D.L, Ohlemacher, S.I, Henderson, J.P. | Deposit date: | 2017-10-12 | Release date: | 2018-10-31 | Last modified: | 2023-10-04 | Method: | X-RAY DIFFRACTION (1.4 Å) | Cite: | YbtT is a low-specificity type II thioesterase that maintains production of the metallophore yersiniabactin in pathogenic enterobacteria. J. Biol. Chem., 293, 2018
|
|
6BA8
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 6ba8 by Molmil](/molmil-images/mine/6ba8) | YbtT - Type II thioesterase from Yersiniabactin NRPS/PKS biosynthetic pathway | Descriptor: | Iron aquisition yersiniabactin synthesis enzyme, YbtT | Authors: | Brett, T.J, Kober, D.L, Ohlemacher, S.I, Henderson, J.P. | Deposit date: | 2017-10-12 | Release date: | 2018-10-31 | Last modified: | 2023-10-04 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | YbtT is a low-specificity type II thioesterase that maintains production of the metallophore yersiniabactin in pathogenic enterobacteria. J. Biol. Chem., 293, 2018
|
|
5EKO
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 5eko by Molmil](/molmil-images/mine/5eko) | Crystal structure of MAPK13 complex with inhibitor | Descriptor: | 3-(4-methyl-1H-imidazol-1-yl)-N-[4-(pyridin-4-yloxy)phenyl]benzamide, Mitogen-activated protein kinase 13 | Authors: | Brett, T.J, Miller, C.A, Yurtsever, Z. | Deposit date: | 2015-11-03 | Release date: | 2016-07-06 | Last modified: | 2023-09-27 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes. Biochim.Biophys.Acta, 1860, 2016
|
|
5EKN
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 5ekn by Molmil](/molmil-images/mine/5ekn) | Crystal structure of MAPK13 complex with inhibitor | Descriptor: | 1-(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)-3-[4-(pyridin-4-ylsulfanyl)phenyl]urea, Mitogen-activated protein kinase 13 | Authors: | Brett, T.J, Miller, C.A, Yurtsever, Z. | Deposit date: | 2015-11-03 | Release date: | 2016-07-06 | Last modified: | 2023-09-27 | Method: | X-RAY DIFFRACTION (2.594 Å) | Cite: | First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes. Biochim.Biophys.Acta, 1860, 2016
|
|
6PYO
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 6pyo by Molmil](/molmil-images/mine/6pyo) | |
6PYX
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 6pyx by Molmil](/molmil-images/mine/6pyx) | |
1KYD
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 1kyd by Molmil](/molmil-images/mine/1kyd) | |
1KY6
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 1ky6 by Molmil](/molmil-images/mine/1ky6) | |
1KYF
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 1kyf by Molmil](/molmil-images/mine/1kyf) | |
1KY7
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 1ky7 by Molmil](/molmil-images/mine/1ky7) | |
1KYU
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 1kyu by Molmil](/molmil-images/mine/1kyu) | |
1R0D
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 1r0d by Molmil](/molmil-images/mine/1r0d) | |
3NI0
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 3ni0 by Molmil](/molmil-images/mine/3ni0) | Crystal Structure of Mouse BST-2/Tetherin Ectodomain | Descriptor: | Bone marrow stromal antigen 2, ISOPROPYL ALCOHOL | Authors: | Scheaffer, S.M, Brett, T.J. | Deposit date: | 2010-06-14 | Release date: | 2010-11-17 | Last modified: | 2023-09-06 | Method: | X-RAY DIFFRACTION (1.601 Å) | Cite: | Structural and Biophysical Analysis of BST-2/Tetherin Ectodomains Reveals an Evolutionary Conserved Design to Inhibit Virus Release. J.Biol.Chem., 286, 2011
|
|
4MYG
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 4myg by Molmil](/molmil-images/mine/4myg) | MAPK13, active form | Descriptor: | Mitogen-activated protein kinase 13 | Authors: | Yurtsever, Z, Brett, T.J, Scheaffer, S.M. | Deposit date: | 2013-09-27 | Release date: | 2015-03-25 | Last modified: | 2023-12-06 | Method: | X-RAY DIFFRACTION (2.594 Å) | Cite: | The crystal structure of phosphorylated MAPK13 reveals common structural features and differences in p38 MAPK family activation. Acta Crystallogr.,Sect.D, 71, 2015
|
|
4YNO
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 4yno by Molmil](/molmil-images/mine/4yno) | |
4EYM
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 4eym by Molmil](/molmil-images/mine/4eym) | MAPK13 complex with inhibitor | Descriptor: | 2-(morpholin-4-yl)-N-[4-(pyridin-4-yloxy)phenyl]pyridine-4-carboxamide, Mitogen-activated protein kinase 13 | Authors: | Miller, C.A, Brett, T.J. | Deposit date: | 2012-05-01 | Release date: | 2012-12-19 | Last modified: | 2024-02-28 | Method: | X-RAY DIFFRACTION (2.353 Å) | Cite: | IL-13-induced airway mucus production is attenuated by MAPK13 inhibition. J.Clin.Invest., 122, 2012
|
|
4EYJ
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 4eyj by Molmil](/molmil-images/mine/4eyj) | MAPK13 Complex with inhibitor | Descriptor: | 1-(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)-3-[4-(pyridin-4-yloxy)phenyl]urea, Mitogen-activated protein kinase 13 | Authors: | Miller, C.A, Brett, T.J. | Deposit date: | 2012-05-01 | Release date: | 2012-12-19 | Last modified: | 2023-09-13 | Method: | X-RAY DIFFRACTION (2.102 Å) | Cite: | IL-13-induced airway mucus production is attenuated by MAPK13 inhibition. J.Clin.Invest., 122, 2012
|
|